Literature DB >> 21034831

Restricted expression of EBV encoded proteins in in vitro infected CLL cells.

Eva Klein1, Noemi Nagy.   

Abstract

CLL is not associated with EBV. CLL cells separated from blood express CR2, the complement receptor that serves also as EBV receptor. Thus CLL cells can be infected in vitro with the virus, however, in contrast to normal B lymphocytes, only rare CLL clones yield transformed lines. This is due to a restricted EBV encoded protein expression in the CLL cells, they express EBNAs, the virus encoded proteins that are localized in the nucleus, but not the cell membrane associated LMP-1, that is also pivotal for the virus induced transformation of B lymphocytes. This expression pattern seems to be unique to a defined B cell maturation window that is represented by the CLL cells. We named this restricted viral expression as Type IIb. Such B lymphocytes have been encountered in lymphoid tissues of infectious mononucleosis (IM) and in post transplant lymphoproliferative disease (PTLD). Moreover, they were shown in tissues of EBV infected "humanized" mice. The EBV encoded protein expression pattern may serve as a marker for the B cell differentiation stage from which CLL clones can develop.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034831     DOI: 10.1016/j.semcancer.2010.10.013

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  4 in total

1.  Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.

Authors:  Anders Rosén; Ann-Charlotte Bergh; Peter Gogok; Chamilly Evaldsson; Anna Lanemo Myhrinder; Eva Hellqvist; Abu Rasul; Magnus Björkholm; Mattias Jansson; Larry Mansouri; Anquan Liu; Bin Tean Teh; Richard Rosenquist; Eva Klein
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

2.  Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.

Authors:  Carlo Visco; Erika Falisi; Ken H Young; Michela Pascarella; Omar Perbellini; Giuseppe Carli; Elisabetta Novella; Davide Rossi; Ilaria Giaretta; Chiara Cavallini; Maria Teresa Scupoli; Anita De Rossi; Emanuele Stefano Giovanni D'Amore; Mario Rassu; Gianluca Gaidano; Giovanni Pizzolo; Achille Ambrosetti; Francesco Rodeghiero
Journal:  Oncotarget       Date:  2015-07-30

3.  EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency.

Authors:  Eva Klein; Noémi Nagy; Abu Eahsan Rasul
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

4.  Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia.

Authors:  Panagiotis T Diamantopoulos; Maria Sofotasiou; Zafiroula Georgoussi; Nefeli Giannakopoulou; Vasiliki Papadopoulou; Athanasios Galanopoulos; Elina Kontandreopoulou; Panagiotis Zervakis; Paschalina Pallaki; Fani Kalala; Marie-Christine Kyrtsonis; Aglaia Dimitrakopoulou; Theodoros Vassilakopoulos; Maria Angelopoulou; Nikolaos Spanakis; Nora-Athina Viniou
Journal:  Cancer Med       Date:  2016-07-01       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.